We are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver diseases utilizing our proprietary bile acid chemistry.
Our product candidates have the potential to treat orphan and more prevalent diseases for which there currently are limited therapeutic solutions.